Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential mycophenolate + prednisolone vs standard supportive therapy in progressive IgA nephritis
2007-000443-99Phase 3Terminated
- Sponsor
- University Hospital Ulm
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mycophenolate sodium and prednisolone in IgA nephropathy (IgAN) and Glomerulonephritis (GN) (2 arms), sponsored by University Hospital Ulm. Primary endpoints: Reduction in frequency of spontaneous GFR loss ≥20% and Prevention of further GFR loss. Started Nov 2008; status: terminated.
02
Drugs
mycophenolate sodiumprednisolone
03
Conditions
IgA nephropathy (IgAN)Glomerulonephritis (GN)
Beyond the preview
Go deeper on 2007-000443-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000443-99.